asymchem laboratories tianjin co ltd - ASLTY
ASLTY
Close Chg Chg %
7.45 0.70 9.40%
Closed Market
8.15
+0.70 (9.40%)
Volume: 100.00
Last Updated:
Aug 7, 2026, 12:11 PM EDT
Company Overview: asymchem laboratories tianjin co ltd - ASLTY
ASLTY Key Data
| Open $8.15 | Day Range 8.15 - 8.15 |
| 52 Week Range N/A - N/A | Market Cap $583.97M |
| Shares Outstanding 55.67M | Public Float N/A |
| Beta -0.14 | Rev. Per Employee N/A |
| P/E Ratio 50.80 | EPS $0.21 |
| Yield 64.65% | Dividend $0.07 |
| EX-DIVIDEND DATE Jun 26, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 21.26 |
ASLTY Performance
No Data Available
ASLTY Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
Full Ratings ➔
An error occurred while fetching the data.
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Asymchem Laboratories Tianjin Co Ltd - ASLTY
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 1.52B | 1.10B | 795.84M | 924.13M | |
Sales Growth
| +111.53% | -27.71% | -27.54% | +16.12% | |
Cost of Goods Sold (COGS) incl D&A
| 818.68M | 557.41M | 483.46M | 556.60M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 53.76M | 68.72M | 73.11M | 79.96M | |
Depreciation
| 47.66M | 62.84M | 67.25M | 74.69M | |
Amortization of Intangibles
| 3.09M | 2.65M | 2.58M | 1.94M | |
COGS Growth
| +99.39% | -31.91% | -13.27% | +15.13% | |
Gross Income
| 700.57M | 540.89M | 312.38M | 367.53M | |
Gross Income Growth
| +127.72% | -22.79% | -42.25% | +17.66% | |
Gross Profit Margin
| +46.11% | +49.25% | +39.25% | +39.77% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 233.43M | 222.33M | 216.93M | 209.96M | |
Research & Development
| 99.71M | 96.54M | 82.02M | 79.54M | |
Other SG&A
| 133.72M | 125.80M | 134.91M | 130.42M | |
SGA Growth
| +63.65% | -4.75% | -2.43% | -3.21% | |
Other Operating Expense
| 5.18M | 5.86M | 11.49M | 13.15M | |
Unusual Expense
| (12.36M) | (1.42M) | (2.17M) | (3.06M) | |
EBIT after Unusual Expense
| 474.31M | 314.12M | 86.13M | 147.48M | |
Non Operating Income/Expense
| 75.62M | 48.00M | 60.82M | 28.23M | |
Non-Operating Interest Income
| 11.38M | 37.73M | 29.24M | 28.24M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 1.66M | 892.27K | 1.40M | 1.88M | |
Interest Expense Growth
| +36.03% | -46.28% | +57.03% | +34.44% | |
Gross Interest Expense
| 1.66M | 892.27K | 1.40M | 1.88M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 548.27M | 361.23M | 145.55M | 173.82M | |
Pretax Income Growth
| +195.46% | -34.12% | -59.71% | +19.42% | |
Pretax Margin
| +36.09% | +32.89% | +18.29% | +18.81% | |
Income Tax
| 63.90M | 43.23M | 18.98M | 22.22M | |
Income Tax - Current - Domestic
| 66.62M | 44.27M | 21.43M | 29.23M | |
Income Tax - Current - Foreign
| - | - | - | - | - |
Income Tax - Deferred - Domestic
| (2.72M) | (1.04M) | (2.45M) | (7.01M) | |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 489.27M | 317.69M | 130.02M | 156.73M | |
Minority Interest Expense
| (1.04M) | (2.54M) | (1.83M) | (824.62K) | |
Net Income
| 490.31M | 320.23M | 131.86M | 157.55M | |
Net Income Growth
| +195.73% | -34.69% | -58.82% | +19.49% | |
Net Margin Growth
| +32.27% | +29.16% | +16.57% | +17.05% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 490.31M | 320.23M | 131.86M | 157.55M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 490.31M | 320.23M | 131.86M | 157.55M | |
EPS (Basic)
| 0.6698 | 0.4423 | 0.1872 | 0.2209 | |
EPS (Basic) Growth
| +174.85% | -33.97% | -57.68% | +18.00% | |
Basic Shares Outstanding
| 732.07M | 724.05M | 704.21M | 713.15M | |
EPS (Diluted)
| 0.6683 | 0.4413 | 0.1872 | 0.2209 | |
EPS (Diluted) Growth
| +174.91% | -33.97% | -57.58% | +18.00% | |
Diluted Shares Outstanding
| 733.70M | 724.45M | 704.21M | 713.15M | |
EBITDA
| 515.71M | 381.41M | 157.07M | 224.38M | |
EBITDA Growth
| +163.38% | -26.04% | -58.82% | +42.86% | |
EBITDA Margin
| +33.95% | +34.73% | +19.74% | +24.28% |
An error occurred while fetching the data.
SEC Filings for Asymchem Laboratories Tianjin Co Ltd - ASLTY
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
An error occurred while fetching the data.